| Interaction Color Code | Clinical Bottom Line | Clinical Effects | Drug 1 effect | Drug 2 dose | Drug 2 effect | Management | |
|---|---|---|---|---|---|---|---|
| Lenacapavir Flibanserin | Red: Avoid combination | Do not coadminster: potentially increased levels of flibanserin | Potential increased risk of GI adverse effects, insomnia, dry mouth, tachycardia |
Use alternative agents. |
|||
| Darunavir Flibanserin 930 | Red: Avoid combination | Do not coadminister: Potential for increased flibanserin levels | Potential for increased risk of flibanserin adverse effects |
Contraindicated. Use alternative agents. |
|||
| Elvitegravir Flibanserin 207 | Red: Avoid combination | Do not coadminister: Potential for increased levels of flibanserin | Potential for increased risk of flibanserin adverse effects |
Use alternative agents |
